These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7553076)

  • 1. Determination of anti GAD65 autoantibodies with an ELISA before and after standardization with the new international reference serum.
    Pfützner A; Forst T; Ambrosch A; Schmitz H; Lichtwald K; Beyer J
    Exp Clin Endocrinol Diabetes; 1995; 103(2):123-5. PubMed ID: 7553076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition.
    Daw K; Ujihara N; Atkinson M; Powers AC
    J Immunol; 1996 Jan; 156(2):818-25. PubMed ID: 8543838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of 2 alternative enzyme-linked immunosorbent assays for routine screening of glutamic acid decarboxylase autoantibodies.
    Villalba A; Valdez SN; Iacono RF; Poskus E
    Clin Chim Acta; 2007 Feb; 376(1-2):82-7. PubMed ID: 16963012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a new anti-glutamic acid decarboxylase (GAD) enzyme-linked immunosorbent assay (ELISA) with radioimmunoassay methods: a multicenter study.
    Wild T; Scherbaum WA; Gleichmann H; Landt M; Santiago J; Endl J; Landgraf R; Cavallo MG; Ganz M; Pozzilli P
    Horm Metab Res; 1997 Aug; 29(8):403-6. PubMed ID: 9288579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of GAD65 (and IA-2) antibodies in Japanese IDDM patients by a new immunoprecipitation assay based on recombinant human GAD65.
    Akamine H; Komiya I; Shimabukuro T; Asawa T; Tanaka H; Yagi N; Taira T; Nagata K; Arakaki K; Wakugami T; Takasu N; Powell MJ; Furmaniak J; Smith BR
    Diabet Med; 1997 Sep; 14(9):778-84. PubMed ID: 9300229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and testing of diabetes autoantibody controls.
    Brooking H; Powell MJ; Amoroso M; Betterle C; Pedini B; Coco G; Furmaniak J; Smith BR
    Ann N Y Acad Sci; 2008 Dec; 1150():316-9. PubMed ID: 19120319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of hydroxyl radical modified GAD65: a potential autoantigen in type 1 diabetes.
    Khan MW; Sherwani S; Khan WA; Ali R
    Autoimmunity; 2009 Feb; 42(2):150-8. PubMed ID: 19085183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of immunoassays for the detection of anti-GAD65 autoantibodies in patients with diabetes mellitus.
    Pfützner A; Harzer O; Kunt T; Forst T; Abdollahnia N; Löbig M; Krauss H; Engelbach M; Kann P; Beyer J
    Clin Lab; 2000; 46(5-6):275-9. PubMed ID: 10853236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies.
    Davenport C; Radford PM; Al-Bukhari TA; Lai M; Bottazzo GF; Todd I
    Clin Exp Immunol; 1998 Mar; 111(3):497-505. PubMed ID: 9528889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic usefulness of glutamic acid decarboxylase antibodies in stiff-man syndrome].
    Saiz A; Arias M; Fernández-Barreiro A; Mínguez A; Casamitjana R; Tolosa E; Graus F
    Med Clin (Barc); 1998 Mar; 110(10):378-81. PubMed ID: 9567281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of antibodies against both isoforms of glutamate decarboxylase in BB/OK rats by western blotting and immuno trapping enzyme activity assay.
    Lühder F; Woltanski KP; Hamann J; Klöting I; Ziegler B; Ziegler M
    Diabetes Res; 1992; 20(4):97-107. PubMed ID: 1345008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
    Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
    J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.
    Seissler J; Amann J; Mauch L; Haubruck H; Wolfahrt S; Bieg S; Richter W; Holl R; Heinze E; Northemann W
    J Clin Invest; 1993 Sep; 92(3):1394-9. PubMed ID: 8376591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
    Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
    Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral autoimmune responses to glutamic acid decarboxylase have similar target epitopes and subclass that show titer-dependent disease association.
    Piquer S; Belloni C; Lampasona V; Bazzigaluppi E; Vianello M; Giometto B; Bosi E; Bottazzo GF; Bonifacio E
    Clin Immunol; 2005 Oct; 117(1):31-5. PubMed ID: 16027042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GAD65-Reactive T cells in a non-diabetic stiff-man syndrome patient.
    Schloot NC; Batstra MC; Duinkerken G; De Vries RR; Dyrberg T; Chaudhuri A; Behan PO; Roep BO
    J Autoimmun; 1999 Jun; 12(4):289-96. PubMed ID: 10330300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
    Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitive non-isotopic assays for autoantibodies to IA-2 and to a combination of both IA-2 and GAD65.
    Chen S; Willis J; Maclean C; Ananieva-Jordanova R; Amoroso MA; Brooking H; Powell M; Collins A; Bennett S; Mitchell S; Burne P; Furmaniak J; Smith BR
    Clin Chim Acta; 2005 Jul; 357(1):74-83. PubMed ID: 15963796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome.
    Dinkel K; Meinck HM; Jury KM; Karges W; Richter W
    Ann Neurol; 1998 Aug; 44(2):194-201. PubMed ID: 9708541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
    Reinsch B; Zimmy S; Schatz H; Pfohl M
    Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.